A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A hospital has performed a record number of pioneering prostate procedures in one day in a bid to help curb NHS waiting lists ...

CLEVELAND, Oh. - It’s the leading cause of cancer deaths in men 65 and older. Traditional treatment includes chemotherapy, immunotherapy and radiation. Urologist Dr. Ruben Olivares specializes in ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.